Rob NoelIndependent Consultant at 55BiomarketsSpeaker
Profile
Rob has over 20 years experience in developing, implementing & commercialising new biomanufacturing technologies for plasma, vaccine, rPro, ADC and CGT. He is now consulting on quantifying manufacturing improvement projects.
Agenda Sessions
Sustainability and Economics of Gene Therapy Vector Manufacturing – Prioiritsing Effort
, 16:30View Session